Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Mercaptopurine

Brand: 
NICE TA: 
Indication: Ulcerative colitis and Crohn's ONLY; only for inflammatory bowel diseases when patients are unable to tolerate azathioprine.
Disease category: Gastro-intestinal system
Commissioning responsibility: CCG
PbR excluded: No

Background

LMMG is adopting the local decisions made prior to April 2013

Recommendation

LMMG recommendation: Amber2
Click here to find the definitions for the colour classifications

Reason for decision:  Requires significant monitoring

Supporting documents:

AzathioprineMercaptopurine Shared Care Guideline (Version 2.1) (144.8 KiB)

DMARDs Shared Care Agreement V1.1 (124.0 KiB)

**Please note - For Fylde & Wyre CCG DMARD Shared Care Guidelines please use the versions available on the CCG website 

**Please note - For Blackpool CCG DMARD Shared Care Guidelines please use the versions available on the CCG website 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber2

Amber2

Amber2

Amber2

Amber2

Amber2